Serum estradiol is associated with lean mass in elderly Swedish men

European Journal of Endocrinology

Volumn 162, Issue 4, 2010, Pages 737-745

  Vandenput, Liesbeth ^a   Mellström, Dan ^a   Karlsson, Magnus K ^b,c   Orwoll, Eric ^d   Labrie, Fernand ^e   Ljunggren, Östen ^f   Ohlsson, Claes ^a  

^a UNIVERSITY OF GOTHENBURG   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^e LAVAL UNIVERSITY   (Canada)

^f UPPSALA UNIVERSITY   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; SEX HORMONE BINDING GLOBULIN; TESTOSTERONE;

AGED; ARTICLE; BODY COMPOSITION; BODY FAT; BODY MASS; COHORT ANALYSIS; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRADIOL BLOOD LEVEL; HUMAN; HYPOGONADISM; IMMUNORADIOMETRIC ASSAY; LEAN BODY WEIGHT; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SWEDEN; TESTOSTERONE BLOOD LEVEL; TRUNK;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; BODY COMPOSITION; COHORT STUDIES; CROSS-SECTIONAL STUDIES; ESTRADIOL; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; LOGISTIC MODELS; MALE; SEX HORMONE-BINDING GLOBULIN; SWEDEN; TESTOSTERONE;

EID: 77950325428     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-09-0696     Document Type: Article

References (46)

1. Kaufman JM & Vermeulen A. The decline of androgen levels in elderly men and its clinical and therapeutic implications. Endocrine Reviews 2005 26 833-876.
2. Liverman CT & Blazer DG. Testosterone and Aging: Clinical Research Directions. Washington, DC: Institute of Medicine, National Academies Press, 2004.
3. Liu PY, Swerdloff RS & Veldhuis JD. The rationale, efficacy and safety of androgen therapy in older men: future research and current practice recommendations. Journal of Clinical Endocrinology and Metabolism 2004 89 4789-4796.
4. Wu FC. Guideline for male testosterone therapy: a European perspective. Journal of Clinical Endocrinology and Metabolism 2007 92 418-419.
5. Bhasin S, Cunningham GR, Hayes FJ, Matsumoto AM, Snyder PJ, Swerdloff RS & Montori VM. Testosterone therapy in adult men with androgen deficiency syndromes: an Endocrine Society Clinical Practice Guideline. Journal of Clinical Endocrinology and Metabolism 2006 91 1995-2010.
6. Seidell JC, Bjorntorp P, Sjostrom L, Kvist H & Sannerstedt R. Visceral fat accumulation in men is positively associated with insulin, glucose, and C-peptide levels, but negatively with testosterone levels. Metabolism 1990 39 897-901.
7. Couillard C, Gagnon J, Bergeron J, Leon AS, Rao DC, Skinner JS, Wilmore JH, Despres JP & Bouchard C. Contribution of body fatness and adipose tissue distribution to the age variation in plasma steroid hormone concentrations in men: the HERITAGE Family Study. Journal of Clinical Endocrinology and Metabolism 2000 85 1026-1031.
8. van den Beld AW, De Jong FH, Grobbee DE, Pols HAP & Lamberts SWJ. Measures of bioavailable serum testosterone and estradiol and their relationships with muscle strength, bone density, and body composition in elderly men. Journal of Clinical Endocrinology and Metabolism 2000 85 3276-3282.
9. Muller M, den Tonkelaar I, Thijssen JH, Grobbee DE & van der Schouw YT. Endogenous sex hormones in men aged 40-80 years. European Journal of Endocrinology 2003 149 583-589.
10. Szulc P, Uusi-Rasi K, Claustrat B, Marchand F, Beck TJ & Delmas PD. Role of sex steroids in the regulation of bone morphology in men. The MINOS Study. Osteoporosis International 2004 15 909-917.
11. Orwoll E, Lambert LC, Marshall LM, Blank J, Barrett-Connor E, Cauley J, Ensrud K & Cummings SR. Endogenous testosterone levels, physical performance, and fall risk in older men. Archives of Internal Medicine 2006 166 2124-2131.
12. Travison TG, Araujo AB, Kupelian V, O'Donnell AB & McKinlay JB. The relative contributions of aging, health, and lifestyle factors to serum testosterone decline in men. Journal of Clinical Endocrinology and Metabolism 2007 92 549-555.
13. Wu FC, Tajar A, Pye SR, Silman AJ, Finn JD, O'Neill TW, Bartfai G, Casanueva F, Forti G, Giwercman A, Huhtaniemi IT, Kula K, Punab M, Boonen S & Vanderschueren D. Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study. Journal of Clinical Endocrinology and Metabolism 2008 93 2737-2745.
14. Hall SA, Esche GR, Araujo AB, Travison TG, Clark RV,Williams RE & McKinlay JB. Correlates of low testosterone and symptomatic androgen deficiency in a population-based sample. Journal of Clinical Endocrinology and Metabolism 2008 93 3870-3877.
15. Nielsen TL, Hagen C, Wraae K, Brixen K, Petersen PH, Haug E, Larsen R & Andersen M. Visceral and subcutaneous adipose tissue assessed by magnetic resonance imaging in relation to circulating androgens, sex hormone-binding globulin, and luteinizing hormone in young men. Journal of Clinical Endocrinology and Metabolism 2007 92 2696-2705.
16. Vandenput L, Mellstrom D, Lorentzon M, Swanson C, Karlsson MK, Brandberg J, Lonn L, Orwoll E, Smith U, Labrie F, Ljunggren O, Tivesten A & Ohlsson C. Androgens and glucuronidated androgen metabolites are associated with metabolic risk factors in men. Journal of Clinical Endocrinology and Metabolism 2007 92 4130-4137.
17. Baumgartner RN, Waters DL, Gallagher D, Morley JE & Garry PJ. Predictors of skeletal muscle mass in elderly men and women. Mechanisms of Ageing and Development 1999 107 123-136.
18. Szulc P, Duboeuf F, Marchand F & Delmas PD. Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS Study. American Journal of Clinical Nutrition 2004 80 496-503.
19. Roy TA, Blackman MR, Harman SM, Tobin JD, Schrager M & Metter EJ. Interrelationships of serum testosterone and free testosterone index with FFM and strength in aging men. American Journal of Physiology. Endocrinology and Metabolism 2002 283 E284-E294.
20. Wang C, Catlin DH, Demers LM, Starcevic B & Swerdloff RS. Measurement of total serum testosterone in adult men: comparison of current laboratory methods versus liquid chromatography-tandem mass spectrometry. Journal of Clinical Endocrinology and Metabolism 2004 89 534-543.
21. Lee JS, Ettinger B, Stanczyk FZ, Vittinghoff E, Hanes V, Cauley JA, Chandler W, Settlage J, Beattie MS, Folkerd E, Dowsett M, Grady D & Cummings SR. Comparison of methods to measure low serum estradiol levels in postmenopausal women. Journal of Clinical Endocrinology and Metabolism 2006 91 3791-3797.
22. Mellstrom D, Johnell O, Ljunggren O, Eriksson AL, Lorentzon M, Mallmin H, Holmberg A, Redlund-Johnell I, Orwoll E & Ohlsson C. Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden. Journal of Bone and Mineral Research 2006 21 529-535.
23. Labrie F, Belanger A, Belanger P, Berube R, Martel C, Cusan L, Gomez J, Candas B, Castiel I, Chaussade V, Deloche C & Leclaire J. Androgen glucuronides, instead of testosterone, as the new markers of androgenic activity in women. Journal of Steroid Biochemistry and Molecular Biology 2006 99 182-188.
24. Vandenput L, Labrie F, Mellstrom D, Swanson C, Knutsson T, Peeker R, Ljunggren O, Orwoll E, Eriksson AL, Damber JE & Ohlsson C. Serum levels of specific glucuronidated androgen metabolites predict BMD and prostate volume in elderly men. Journal of Bone and Mineral Research 2007 22 220-227.
25. Vermeulen A, Verdonck L & Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. Journal of Clinical Endocrinology and Metabolism 1999 84 3666-3672.
26. Bhasin S, Woodhouse L, Casaburi R, Singh AB, Bhasin D, Berman N, Chen X, Yarasheski KE, Magliano L, Dzekov C, Dzekov J, Bross R, Phillips J, Sinha-Hikim I, Shen R & Storer TW. Testosterone dose-response relationships in healthy young men. American Journal of Physiology. Endocrinology and Metabolism 2001 281 E1172-E1181.
27. Storer TW, Woodhouse L, Magliano L, Singh AB, Dzekov C, Dzekov J & Bhasin S. Changes in muscle mass, muscle strength, and power but not physical function are related to testosterone dose in healthy older men. Journal of the American Geriatrics Society 2008 56 1991-1999.
28. Sattler FR, Castaneda-Sceppa C, Binder EF, Schroeder ET, Wang Y, Bhasin S, Kawakubo M, Stewart Y, Yarasheski KE, Ulloor J, Colletti P, Roubenoff R & Azen SP. Testosterone and growth hormone improve body composition and muscle performance in older men. Journal of Clinical Endocrinology and Metabolism 2009 94 1991-2001.
29. Muller M, van den Beld AW, van der Schouw YT, Grobbee DE & Lamberts SW. Effects of dehydroepiandrosterone and atamestane supplementation on frailty in elderly men. Journal of Clinical Endocrinology and Metabolism 2006 91 3988-3991.
30. Burnett-Bowie SA, Roupenian KC, Dere ME, Lee H & Leder BZ. Effects of aromatase inhibition in hypogonadal older men: a randomized, double-blind, placebo-controlled trial. Clinical Endocrinology 2009 70 116-123.
31. Callewaert F, Venken K, Ophoff J, De Gendt K, Torcasio A, van Lenthe GH, Van Oosterwyck H, Boonen S, Bouillon R, Verhoeven G & Vanderschueren D. Differential regulation of bone and body composition in male mice with combined inactivation of androgen and estrogen receptor-α. FASEB Journal 2009 23 232-240.
32. Glenmark B, Nilsson M, Gao H, Gustafsson JA, Dahlman-Wright K &Westerblad H. Difference in skeletal muscle function in males vs. females: role of estrogen receptor-b. American Journal of Physiology. Endocrinology and Metabolism 2004 287 E1125-E1131.
33. Brown M, Ning J, Ferreira JA, Bogener JL & Lubahn DB. Estrogen receptor-α and -β and aromatase knockout effects on lower limb muscle mass and contractile function in female mice. American Journal of Physiology. Endocrinology and Metabolism 2009 296 E854-E861.
34. Vandenput L, Boonen S, Van Herck E, Swinnen JV, Bouillon R & Vanderschueren D. Evidence from the aged orchidectomized male rat model that 17β-estradiol is a more effective bone-sparing and anabolic agent than 5α-dihydrotestosterone. Journal of Bone and Mineral Research 2002 17 2080-2086.
35. Preston RL. Hormone containing growth promoting implants in farmed livestock. Advanced Drug Delivery Reviews 1999 38 123-138.
36. Longcope C, Pratt JH, Schneider SH & Fineberg SE. Aromatization of androgens by muscle and adipose tissue in vivo. Journal of Clinical Endocrinology and Metabolism 1978 46 146-152.
37. Larionov AA, Vasyliev DA, Mason JI, Howie AF, Berstein LM & Miller WR. Aromatase in skeletal muscle. Journal of Steroid Biochemistry and Molecular Biology 2003 84 485-492.
38. Khosla S, Melton LJ III, Atkinson EJ & O'Fallon WM. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. Journal of Clinical Endocrinology and Metabolism 2001 86 3555-3561.
39. Riggs BL, Khosla S & Melton LJ. Sex steroids and the construction and conservation of the adult skeleton. Endocrine Reviews 2002 23 279-302.
40. Amin S, Zhang Y, Felson DT, Sawin CT, Hannan MT,Wilson PW & Kiel DP. Estradiol, testosterone, and the risk for hip fractures in elderly men from the Framingham Study. American Journal of Medicine 2006 119 426-433.
41. Mellstrom D, Vandenput L, Mallmin H, Holmberg AH, Lorentzon M, Oden A, Johansson H, Orwoll ES, Labrie F, Karlsson MK, Ljunggren O & Ohlsson C. Older men with low serum estradiol and high serum SHBG have an increased risk of fractures. Journal of Bone and Mineral Research 2008 23 1552-1560.
42. Travison TG, Araujo AB, Beck TJ,Williams RE, Clark RV, Leder BZ & McKinlay JB. Relation between serum testosterone, serum estradiol, sex hormone-binding globulin, and geometrical measures of adult male proximal femur strength. Journal of Clinical Endocrinology and Metabolism 2009 94 853-860.
43. Rosenbaum M, Leibel RL & Hirsch J. Obesity. New England Journal of Medicine 1997 337 396-407.
44. Blouin K, Boivin A & Tchernof A. Androgens and body fat distribution. Journal of Steroid Biochemistry and Molecular Biology 2008 108 272-280.
45. Lapidus L, Lindstedt G, Lundberg PA, Bengtsson C & Gredmark T. Concentrations of sex-hormone binding globulin and corticosteroid binding globulin in serum in relation to cardiovascular risk factors and to 12-year incidence of cardiovascular disease and overall mortality in postmenopausal women. Clinical Chemistry 1986 32 146-152.
46. Ding EL, Song Y, Manson JE, Hunter DJ, Lee CC, Rifai N, Buring JE, Gaziano JM & Liu S. Sex hormone-binding globulin and risk of type 2 diabetes in women and men. New England Journal of Medicine 2009 361 1152-1163.